Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neurocrine Bioscienc
(NQ:
NBIX
)
137.92
+0.09 (+0.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,245,664
Open
137.83
Bid (Size)
134.50 (1)
Ask (Size)
141.00 (2)
Prev. Close
137.83
Today's Range
135.97 - 138.72
52wk Range
89.04 - 148.37
Shares Outstanding
98,700,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind
March 23, 2024
DexCom, Blackstone and Royal Caribbean head this list of five stocks.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
NASDAQ:NBIX is not too expensive for the growth it is showing.
March 20, 2024
NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) is showing decent growth, but is still valued reasonably.
Via
Chartmill
Performance
YTD
+4.70%
+4.70%
1 Month
+1.39%
+1.39%
3 Month
+4.37%
+4.37%
6 Month
+19.76%
+19.76%
1 Year
+42.04%
+42.04%
More News
Read More
Exploring the Growth Potential of NASDAQ:NBIX as It Nears a Breakout.
March 20, 2024
Via
Chartmill
Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform
March 19, 2024
Via
Benzinga
Madrigal Pharmaceuticals Stock Hits 80-Plus Relative Strength Rating Benchmark
March 18, 2024
Via
Investor's Business Daily
Why Quality-Oriented Investors Should Consider NASDAQ:NBIX.
March 15, 2024
Via
Chartmill
Decoding 8 Analyst Evaluations For Neurocrine Biosciences
March 13, 2024
Via
Benzinga
Is NASDAQ:NBIX on the Verge of a Major Breakout as a Strong Growth Stock?
February 28, 2024
Via
Chartmill
AI Plays HubSpot, Arista Networks Lead Five Stocks Near Buy Points In Classic Base
March 16, 2024
Via
Investor's Business Daily
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
NASDAQ:NBIX is probably undervalued for the fundamentals it is displaying.
March 14, 2024
Via
Chartmill
In-Depth Examination Of 8 Analyst Recommendations For Neurocrine Biosciences
March 13, 2024
Via
Benzinga
3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success
March 06, 2024
Via
InvestorPlace
Amicus Therapeutics Stock Sees RS Rating Improve To 74
March 05, 2024
Via
Investor's Business Daily
Investors should take note of NASDAQ:NBIX, a growth stock that remains attractively priced.
February 28, 2024
Via
Chartmill
Breaking Down Neurocrine Biosciences: 8 Analysts Share Their Views
February 08, 2024
Via
Benzinga
Earnings Scheduled For February 7, 2024
February 07, 2024
Via
Benzinga
Exploring the Growth Potential of NASDAQ:NBIX as It Nears a Breakout.
February 07, 2024
Via
Chartmill
Beam Therapeutics Stock Jumps To Higher RS Level On Earnings Beat
February 27, 2024
Via
Investor's Business Daily
Agios Pharmaceuticals Stock Earns RS Rating Upgrade; Hits Key Benchmark
February 23, 2024
Via
Investor's Business Daily
Beam Therapeutics Stock Shows Healthy Relative Strength Improvement
February 16, 2024
Via
Investor's Business Daily
Alkermes Stock Gets RS Rating Upgrade; Profits Surge
February 15, 2024
Via
Investor's Business Daily
CRISPR Therapeutics Stock Shows Rising Relative Strength, Hits 90+
February 13, 2024
Via
Investor's Business Daily
Why This Teva Pharmaceutical Analyst Is Turning Bullish On The Austedo Franchise
February 12, 2024
Via
Benzinga
Amicus Therapeutics Stock Sees Improved Relative Strength Rating
February 09, 2024
Via
Investor's Business Daily
Stock Market Hits Highs As AI Plays Arm, Palantir Skyrocket: Weekly Review
February 08, 2024
Via
Investor's Business Daily
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.